| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.033 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |